Get the Stockscreener App
0.001
16.67%
-0.0002
Protext Pharma Inc Stock (TXTM) Forecast
The Protext Pharma Inc (TXTM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0102, representing a +920.41% increase from the current price of $0.001. The highest analyst price target is $0.0111, and the lowest is $0.00929.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TXTM Price Target
Average 0.00939
(+838.50% Upside)
Long-term TXTM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Protext Pharma Inc financial reports and earnings history, Protext Pharma Inc (TXTM) stock could reach $0.0452 by 2030, $0.1435 by 2040 and $0.1135 by 2050. See the projected annual prices until 2050 of the Protext Pharma Inc stock below:
- Protext Pharma Inc (TXTM) is expected to reach an average price of $0.0808 in 2035, with a high prediction of $0.0952 and a low estimate of $0.082. This indicates an $7,979% rise from the last recorded price of $0.001.
- Protext Pharma Inc (TXTM) stock is projected to chart a bullish course in 2040, with an average price target of $0.1305, representing an $12,948% surge from its current level. The forecast ranges from a conservative $0.1319 to a sky-high $0.1435.
- Our analysts predict Protext Pharma Inc (TXTM) to jump 18,500% by 2045, soaring from $0.0721 to an average price of $0.186, potentially reaching $0.1912. While $0.0721 is the low estimate, the potential upside is significant.
- Protext Pharma Inc (TXTM) stock is expected to climb by 2050, reaching an average of $0.1013, a $10,025% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.1135 and $0.089, respectively, highlighting the market's uncertainty.
Protext Pharma Inc Stock (TXTM) Year by Year Forecast
Protext Pharma Inc Stock (TXTM) Price Forecast for 2024
Our forecast for TXTM stock price in 2024 now indicates an average price target of $0.0076 with a high forecast of $0.0148 and a low forecast of $0.000431. The average prediction reflects an increase of +660.38% from the last recorded price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.00829 | $0.00929 | $0.0111 | +728.70% |
| July, 2024 | $0.00294 | $0.000963 | $0.00664 | +193.65% |
| August, 2024 | $0.00138 | $0.000626 | $0.00473 | +38.47% |
| September, 2024 | $0.00506 | $0.00324 | $0.0045 | +406.11% |
| October, 2024 | $0.0141 | $0.00417 | $0.0118 | +1,314% |
| November, 2024 | $0.0135 | $0.0149 | $0.0148 | +1,252% |
| December, 2024 | $0.00554 | $0.00784 | $0.0123 | +454.11% |
Protext Pharma Inc Stock (TXTM) Price Forecast for 2025
Protext Pharma Inc Stock (TXTM) is expected to reach an average price of $0.0112 in 2025, with a high prediction of $0.0221 and a low estimate of $0.000338. This indicates an +1,021% rise from the last recorded price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.000382 | $0.00192 | $0.00249 | -61.76% |
| February, 2025 | $0.00699 | $0.000338 | $0.00659 | +599.40% |
| March, 2025 | $0.006 | $0.00571 | $0.00628 | +499.84% |
| April, 2025 | $0.0197 | $0.0187 | $0.0181 | +1,870% |
| May, 2025 | $0.0149 | $0.0159 | $0.0184 | +1,393% |
| June, 2025 | $0.0026 | $0.0065 | $0.0131 | +159.52% |
| July, 2025 | $0.00603 | $0.00209 | $0.00163 | +502.70% |
| August, 2025 | $0.00851 | $0.00766 | $0.00869 | +750.87% |
| September, 2025 | $0.0221 | $0.00726 | $0.0198 | +2,112% |
| October, 2025 | $0.0206 | $0.022 | $0.0221 | +1,961% |
| November, 2025 | $0.0125 | $0.0157 | $0.0191 | +1,150% |
| December, 2025 | $0.0047 | $0.007 | $0.00957 | +370.46% |
Protext Pharma Inc Stock (TXTM) Price Forecast for 2026
The predicted value for Protext Pharma Inc (TXTM) in 2026 is set at an average of $0.017. Estimates vary from a peak of $0.0294 to a trough of $0.00453, indicating an +1,596% surge from the present price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0112 | $0.00453 | $0.0108 | +1,019% |
| February, 2026 | $0.00928 | $0.00958 | $0.0101 | +827.87% |
| March, 2026 | $0.0272 | $0.0088 | $0.0256 | +2,623% |
| April, 2026 | $0.0216 | $0.0226 | $0.0257 | +2,057% |
| May, 2026 | $0.0125 | $0.0148 | $0.0195 | +1,147% |
| June, 2026 | $0.0107 | $0.00696 | $0.00723 | +966.93% |
| July, 2026 | $0.0123 | $0.0121 | $0.0129 | +1,126% |
| August, 2026 | $0.0301 | $0.0103 | $0.0278 | +2,910% |
| September, 2026 | $0.0277 | $0.0291 | $0.0294 | +2,670% |
| October, 2026 | $0.0187 | $0.0219 | $0.026 | +1,769% |
| November, 2026 | $0.00979 | $0.0121 | $0.0155 | +879.17% |
| December, 2026 | $0.0154 | $0.00939 | $0.015 | +1,439% |
Protext Pharma Inc Stock (TXTM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Protext Pharma Inc (TXTM) is $0.0244, with a high forecast of $0.0369 and a low forecast of $0.0118. This indicates an +2,338% increase from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0126 | $0.0129 | $0.0141 | +1,159% |
| February, 2027 | $0.0348 | $0.0119 | $0.033 | +3,378% |
| March, 2027 | $0.0282 | $0.0292 | $0.0332 | +2,722% |
| April, 2027 | $0.0182 | $0.0206 | $0.0259 | +1,722% |
| May, 2027 | $0.0153 | $0.0118 | $0.0128 | +1,431% |
| June, 2027 | $0.016 | $0.0164 | $0.0171 | +1,501% |
| July, 2027 | $0.0388 | $0.0134 | $0.0354 | +3,780% |
| August, 2027 | $0.0348 | $0.0362 | $0.0369 | +3,379% |
| September, 2027 | $0.0249 | $0.0281 | $0.0329 | +2,389% |
| October, 2027 | $0.0169 | $0.0203 | $0.0215 | +1,590% |
| November, 2027 | $0.0196 | $0.0143 | $0.0192 | +1,859% |
| December, 2027 | $0.0159 | $0.0162 | $0.0181 | +1,490% |
Protext Pharma Inc Stock (TXTM) Price Forecast for 2028
In 2028, Protext Pharma Inc (TXTM) is projected to reach an average price of $0.0317, with a high projection of $0.0485 and a low estimate of $0.015. This indicates an +3,073% rise from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0423 | $0.015 | $0.0407 | +4,130% |
| February, 2028 | $0.0349 | $0.0359 | $0.0404 | +3,386% |
| March, 2028 | $0.024 | $0.0263 | $0.0323 | +2,297% |
| April, 2028 | $0.0166 | $0.0167 | $0.0183 | +1,559% |
| May, 2028 | $0.0198 | $0.0201 | $0.0213 | +1,877% |
| June, 2028 | $0.047 | $0.0165 | $0.0436 | +4,600% |
| July, 2028 | $0.0419 | $0.0433 | $0.0446 | +4,087% |
| August, 2028 | $0.0311 | $0.0343 | $0.0397 | +3,009% |
| September, 2028 | $0.0222 | $0.0259 | $0.0275 | +2,121% |
| October, 2028 | $0.0238 | $0.0191 | $0.0234 | +2,278% |
| November, 2028 | $0.0192 | $0.0195 | $0.022 | +1,820% |
| December, 2028 | $0.0503 | $0.0181 | $0.0485 | +4,929% |
Protext Pharma Inc Stock (TXTM) Price Forecast for 2029
The 2029 price forecast for Protext Pharma Inc Stock (TXTM) is $0.0379 on average, with a high prediction of $0.0562 and a low estimate of $0.0196. This represents an +3,692% increase from the previous price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0415 | $0.0425 | $0.0482 | +4,050% |
| February, 2029 | $0.0297 | $0.0321 | $0.0387 | +2,873% |
| March, 2029 | $0.0215 | $0.0216 | $0.0238 | +2,045% |
| April, 2029 | $0.0235 | $0.0239 | $0.0255 | +2,252% |
| May, 2029 | $0.0552 | $0.0196 | $0.0518 | +5,420% |
| June, 2029 | $0.0519 | $0.0526 | $0.0524 | +5,093% |
| July, 2029 | $0.0373 | $0.0405 | $0.0479 | +3,629% |
| August, 2029 | $0.0275 | $0.0314 | $0.0335 | +2,652% |
| September, 2029 | $0.027 | $0.024 | $0.0233 | +2,605% |
| October, 2029 | $0.0225 | $0.0228 | $0.0276 | +2,151% |
| November, 2029 | $0.058 | $0.0211 | $0.0562 | +5,704% |
| December, 2029 | $0.0481 | $0.0491 | $0.0558 | +4,715% |
Protext Pharma Inc Stock (TXTM) Price Forecast for 2030
Protext Pharma Inc Stock (TXTM) is expected to reach an average price of $0.0434 in 2030, with a high forecast of $0.0641 and a low forecast of $0.0227. This signifies an +4,240% surge from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0355 | $0.0378 | $0.0452 | +3,448% |
| February, 2030 | $0.0263 | $0.0264 | $0.0294 | +2,532% |
| March, 2030 | $0.0288 | $0.0296 | $0.0297 | +2,780% |
| April, 2030 | $0.0634 | $0.0227 | $0.06 | +6,240% |
| May, 2030 | $0.0592 | $0.0599 | $0.0601 | +5,824% |
| June, 2030 | $0.0487 | $0.0499 | $0.0549 | +4,768% |
| July, 2030 | $0.0328 | $0.0367 | $0.043 | +3,183% |
| August, 2030 | $0.0315 | $0.0288 | $0.0283 | +3,047% |
| September, 2030 | $0.0258 | $0.0261 | $0.0318 | +2,482% |
| October, 2030 | $0.0658 | $0.0242 | $0.0641 | +6,480% |
| November, 2030 | $0.0574 | $0.0579 | $0.0633 | +5,639% |
| December, 2030 | $0.0412 | $0.0436 | $0.0548 | +4,024% |
2.01%
0.17%
Cap:
|
Volume (24h):